Almirall

About Almirall

Almirall is a leading global pharmaceutical company based in Barcelona, focused on medical dermatology. Every day, we partner with health care providers and apply science to deliver meaningful medical solutions for patients today and for future generations.  

Transforming the patients' world

Our purpose is simple yet ambitious: transform the patients’ world by helping them realize their hopes and dreams for a healthy life. 

Our efforts are focused on understanding the real impact skin diseases have on people’s lives.

 

Innovation in skin health

Innovation is at the heart of Almirall. We continuously explore new scientific pathways, technologies, and partnerships to advance skin health. From enhancing existing treatments to developing new therapeutic options, we strive to deliver robust, reliable, and high-quality solutions for the people who need them most. 

We are committed to acting responsibly in everything we do. This includes promoting ethical research, ensuring the quality and safety of our products, and contributing positively to the communities in which we work.

By combining scientific excellence, strong partnerships with the scientific community and healthcare organizations, and a deep commitment to patients, we aim to make a lasting, positive difference in skin health around the world.  

Learn more about Innovation

Almirall at a glance

Discover what defines us as a company.

Slide 1 of 5. 15 Affiliates

15

Affiliates

Some of our major milestones 

These are some of the moments that have defined Almirall’s history.

Slide 1 of 18
Foundation of Laboratory Almirall, S.A
1944
1960
1984
1990
1997
2007
2013
2014
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025

Foundation of Laboratory Almirall, S.A

About Almirall, LLC - U.S.

Company details

Almirall, LLC - U.S. is headquartered in Malvern, Pennsylvania. Our acne, actinic keratosis and dermatitis medicines are trusted by healthcare professionals and patients nationwide. 

Leadership team

The professional experience, educational preparation, energy, and enthusiasm of our US leadership team helps to explain our success. 

Slide 1 of 8
1/8

David Loughery

Chief Financial Officer of Almirall, LLC -- U.S.

Chief Financial Officer of Almirall, LLC

30+ years of pharmaceutical experience at Rhone-Poulenc Rorer, Bristol-Myers Squibb, and Teva. B.A. in Economics, Rutgers University and M.B.A. in Finance, Temple University. 

Paul Rittman

President and General Manager of Almirall, LLC -- U.S.1

President and General Manager of Almirall, LLC

Paul Rittman is President and General Manager of Almirall US, where he leads the company's U.S. dermatology business and serves on Almirall's global Management Board. A pharmaceutical executive with more than 35 years of experience, he has held leadership roles spanning sales, marketing, commercial leadership and general management, including more than a decade leading business units in the U.S. and Canada. Before joining Almirall in 2024, Paul was President and CEO of Helsinn Therapeutics US and SVP and General Manager of U.S. Oncology at Teva. He holds a BA from the University of Missouri and an MBA from St. Ambrose University.

Financial reports

Almirall is a public company listed on the BME Spanish stock exchange.

View our annual and other financial reports at almirall.us/investors.

For business development and partnership opportunities, please email Derick Diaz: derick.diaz@almirall.com

Contact us

Corporate Communications
corporate.communication@almirall.com
(610) 644-7000